Yejia Chen
Overview
Explore the profile of Yejia Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li X, Yu C, Lei L, Liu X, Chen Y, Wang Y, et al.
Glob Heart
. 2024 Mar;
19(1):28.
PMID: 38464557
Background: Previous studies have established blood pressure (BP) as a pivotal factor influencing no-reflow following primary percutaneous coronary intervention (PCI) in patients with ST-elevation acute coronary infarction (STEMI). However, no...
2.
Li X, Yu C, Liu X, Chen Y, Wang Y, Liang H, et al.
J Inflamm Res
. 2024 Feb;
17:1211-1225.
PMID: 38410422
Objective: To evaluate the prognostic value of the systemic immune-inflammatory index (SII) for predicting in-hospital major adverse cardiovascular events (MACEs) in patients with acute myocardial infarction (AMI) and establish a...
3.
Liu X, Gao R, Chen C, Li X, Yu C, Chen Y, et al.
Eur J Nucl Med Mol Imaging
. 2022 Jul;
49(13):4601-4615.
PMID: 35870006
Purpose: Noninvasive detection of high-risk plaques is still challenging. In this study, we aimed to noninvasively assess αvβ3-integrin expression using a customed photoacoustic (PA) computed tomography (PACT)/ultrasound (US) system in...
4.
Chen Y, Li X, Lin X, Liang H, Liu X, Zhang X, et al.
Thromb J
. 2022 Apr;
20(1):24.
PMID: 35488279
Background: Thrombotic events cannot be completely prevented by antithrombotics, implicating a therapeutic gap due to inflammation, a not yet sufficiently addressed mechanism. Neutrophil extracellular traps (NETs) are an essential interface...
5.
Lei L, Dai L, Zhang Q, Lu J, Tang Y, Xiao M, et al.
Front Nutr
. 2022 Apr;
9:861801.
PMID: 35399655
Background: Visceral adiposity index (VAI) is an indicator of visceral fat accumulation and dysfunction. However, little is known about whether VAI is associated with worsening renal function (WRF) in the...
6.
Zhang Q, Lu J, Lei L, Li G, Liang H, Zhang J, et al.
BMC Nephrol
. 2022 Feb;
23(1):62.
PMID: 35144580
Background: To develop a reliable model to predict rapid kidney function decline (RKFD) among population at risk of cardiovascular disease. Methods: In this retrospective study, key monitoring residents including the...
7.
Zhang Q, Zhang J, Lei L, Liang H, Li Y, Lu J, et al.
BMJ Open
. 2021 Nov;
11(11):e047774.
PMID: 34772745
Aims: To develop a nomogram for incident chronic kidney disease (CKD) risk evaluation among community residents with high cardiovascular disease (CVD) risk. Methods: In this retrospective cohort study, 5730 non-CKD...
8.
Warren A, Chen Y, Jones A, Shibue T, Hahn W, Boehm J, et al.
Nat Commun
. 2021 Jan;
12(1):22.
PMID: 33397959
Cell lines are key tools for preclinical cancer research, but it remains unclear how well they represent patient tumor samples. Direct comparisons of tumor and cell line transcriptional profiles are...
9.
Zhang X, Feng T, Zeng X, Liang H, Situ B, Zhang Q, et al.
Front Cardiovasc Med
. 2020 Dec;
7:581362.
PMID: 33304927
Arterial remodeling is a major pathological consequence of hypertension, which is recognized as the most common chronic non-communicable disease. However, the detailed mechanism of how arterial remodeling is induced by...
10.
Corsello S, Nagari R, Spangler R, Rossen J, Kocak M, Bryan J, et al.
Nat Cancer
. 2020 Jul;
1(2):235-248.
PMID: 32613204
Anti-cancer uses of non-oncology drugs have occasionally been found, but such discoveries have been serendipitous. We sought to create a public resource containing the growth inhibitory activity of 4,518 drugs...